Table 1. Intervention Unit Costs.
| Intervention unit | Primary care visit cost, $a | |
|---|---|---|
| Medicare | KPWA | |
| Age group, y | ||
| 18-39 | ||
| Wellness visit | 162.65 | 357.97 |
| Papanicolaou test–only visit | 84.09 | 118.85 |
| 40-64 | ||
| Wellness visit | 171.65 | 365.24 |
| Papanicolaou test–only visit | 84.09 | 118.85 |
| Mailing | ||
| First | 14.73 | 14.73 |
| Second | 14.73 | 14.73 |
| Processing | ||
| Cotesting | ||
| Any abnormal result on Papanicolaou or HPV test | 77.84 | 101.44 |
| Any normal or unsatisfactory result on Papanicolaou or HPV test | 55.35 | 47.04 |
| Normal or positive result for HPV-16 and/or HPV-18 on HPV test kit onlyb | 35.09 | 26.64 |
| HPV test kit result | ||
| Other positive result for high-risk HPV (negative result for HPV-16 and HPV-18) and normal or unsatisfactory result on Papanicolaou test | 55.35 | 47.04 |
| Other positive result for high-risk HPV (negative result for HPV-16 and HPV-18) and abnormal result on Papanicolaou test | 77.84 | 101.44 |
| Any unsatisfactory result on HPV test plus cotest and any normal or unsatisfactory result on Papanicolaou test and second HPV test | 90.44 | 73.68 |
| Colposcopy (plus biopsy and ECC) | 319.41 | 488.18 |
Abbreviations: ECC, endocervical curettage; HPV, human papillomavirus; KPWA, Kaiser Permanente Washington.
a
Including Papanicolaou testing.
b
HPV-16 and HPV-18 are high-risk types known to significantly increase the risk of cervical, vaginal, and vulvar cancer in women.